These days, everyone seems to be only speaking about residential real estate as an asset class. Conversations around it seem ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that its New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, once-daily oral small molecule fatty acid synthase (FASN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback